Market Survey on Air Fluidized Therapy Beds Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Air Fluidized Therapy Beds Market including Pressure Ulcers, and Burns Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Air Fluidized Therapy Bed Market Outlook (2023 to 2033)
Global air fluidized therapy bed sales are expected to reach US$ 653.5 million in 2023, forecast to grow at a CAGR of 5.7% to be valued at US$ 1,135 million from 2023 to 2033. Air fluidized therapy beds have shown an overall growth of a 4.1% CAGR from 2018 to 2022.
Due to the increasing number of accidents and injuries, it has become an important priority for medical centers to provide comfortable and safe resting areas for their patients, which is why demand for air fluidized therapy beds is growing in the market. The technology used in the beds and their comfort are the factors that help beds thrive in an increasingly competitive market.
A growing need for advanced and cutting-edge healthcare products has contributed to the growth of air fluidized therapy beds worldwide. To treat patients with utmost comfort, hospitals and home care providers are placing significant trust in these beds.
Using air fluidized bed therapy is a beneficial way for those who have wounds, ulcers, and other illnesses, and those who are also suffering from intense pain to be relieved. These beds are also used by patients who are suffering from air fluidized bed therapy. A fluidized air bed therapy is mainly used for the treatment of wounds and other skin-related health conditions. As a result, the players are delivering the beds based on the indications.
To treat the skin, air fluidized beds are specially designed to provide a therapeutic level of moisture and other conditions based on the patient's needs. By reducing the pressure and sharing inside the bed, the airflow inside the bed promotes better sleep for all the body parts. In addition to pressure dynamic and temperature controllers, a variety of sensors are being developed for the comfort of patients.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Which Drivers underpin Air Fluidized Therapy Beds Industry Expansion?
With the growing number of diseases, hospitals must provide better conditions for patients to recover. Air fluidized therapy beds are a great solution for this requirement since they provide suitable air circulation and treatment for patients in medical facilities. As a clinical benefit, AFT reduces the number of hospitalizations and emergency room visits for patients with pressure ulcers who are in long-term care facilities.
In addition, these beds decrease mortality rates among patients who have extensive burns and inhalation injuries and promote rapid healing and greater comfort among patients with burn injuries. As medical centers place utmost emphasis on patient comfort, air fluidized therapy beds are likely to gain great popularity shortly.
They reduce friction, shear, and pressure on the patient, so they get a better chance of recovering faster. Increasing technological innovation and advancement in treatments have made these beds in great demand at hospitals worldwide. Furthermore, for patients with skin-related issues, the demand for less noisy and comfortable beds has helped drive the air fluidized therapy bed market.
AHRQ (Agency for Healthcare Research & Quality) estimates that 2.5 million Americans suffer from pressure ulcers every year. As key companies in the fields prepare battery-operated beds that provide comfort to bedridden patients, the need for comfortable beds has also increased.
Attributes
Value
Air Fluidized Therapy Bed Market Size (2023)
US$ 653.5 million
Air Fluidized Therapy Bed Market Projected Size (2033)
US$ 1,135 million
Air Fluidized Therapy Bed Market CAGR (2023 to 2033)
5.7%
Which Factors are limiting the Growth of the Air Fluidized Therapy Beds Market?
While air fluidized therapy beds have many benefits for medical treatment, there are also a few factors that hinder their growth in the market. It is contraindicated to use air fluidized beds for patients with unstable spines, as the lack of adequate back support causes prolonged coughing for the patient. This impedes the market growth for these beds in the market.
In addition, patients who suffer from pulmonary secretion diseases or have trouble moving should refrain from using these beds to maintain their better health. Although this is not a constraint, in the long run, it limits the growth of air fluidized therapy beds in the market.
For many patients, air fluidized therapy beds are a better solution than conventional round therapy beds, but, due to their special features, the manufacturing costs associated with these beds are very high. Additionally, the maintenance costs are likely to be too high for the hospital as well as the patients which further hinder the growth of these beds in the market. As a result, the cost of air-fluidized therapy beds restricts their future growth in the market.
Find your sweet spots for generating winning opportunities in this market.
Comparative View of the Market
Air Fluidized Therapy Bed Market
Attributes
Air Fluidized Therapy Bed Market
CAGR (2023 to 2033)
5.7%
Market Value (2033)
US$ 1,135 million
Growth Factor
Promotes rapid healing
Opportunity
Tech-advancements in treatments
Key Trends
High demand for battery-operated beds
Compression Therapy Market
Attributes
Compression Therapy Market
CAGR (2023 to 2033)
5.4%
Market Value (2033)
US$ 4,840 million
Growth Factor
Growing incidence of venous ulcers
Opportunity
Development of patient-centric products
Key Trends
Applications in promoting mental health
Negative Pressure Wound Therapy Market
Attributes
Negative Pressure Wound Therapy Market
CAGR (2023 to 2033)
5.2%
Market Value (2033)
US$ 6,520 million
Growth Factor
Surging prevalence of chronic wounds
Opportunity
Growing awareness about advanced wound treatment
Key Trends
Rising preference for cost-effective treatment
Regional Analysis
Countries
Market Share (2022)
United States
36%
Germany
8.2%
Japan
3.8%
Does North America Hold a Significant Position in the Global Air Fluidized Therapy Beds Market?
North America was the leading market for Air Fluidized Therapy Beds market and the trend is expected to continue into the forecast period owing to the increasing disposable incomes, and growing demand for consumer electronics in the region.
The growing demand for Air Fluidized Therapy Beds for safe packaging purposes due to the increase in online shopping applications is expected to augment the Air Fluidized Therapy Beds market. As per the Future Market Insights analysis, the North American region is forecast to have a 35% total share of the Air Fluidized Therapy Beds market.
North America is expected to be the next dominant region witnessing high adoption rates for the Air Fluidized Therapy Beds market during the forecast period. With a high concentration of manufacturing industries in North America, demand for the Air Fluidized Therapy Beds market is anticipated to rise in the region.
Approximately one-third of the patients in North America have diseases that prevent them from moving, therefore the need for comfortable beds is high in this region. The demand for air fluidized therapy beds in this area is high since these beds are one of the best options available to patients suffering from this condition.
According to this report, air fluidized therapy beds hold a market share of 37.8% by 2022. North American manufacturers typically dominate the global air fluidized bed market without much effort, which helps the region dominate the industry worldwide. Furthermore, the ongoing research and development contribute greatly to the growth of these beds.
Patients are turning towards these beds for home use instead of being hospitalized, resulting in significant growth in the air fluidized therapy bed market. Even though they are expensive, these beds are highly effective and reduce the healing time for pressure injuries such as ulcers, which is why they are so popular in these regions. A variety of research is being conducted to update these beds so that patients with spinal issues also benefit from them.
How Does Growth of the European Air Fluidized Therapy Beds Market unfold?
The use of air fluidized therapy beds in Europe is on the rise due to the increasing awareness regarding the different types of therapies for better recuperation of patients at home in this region. The market share of these beds has grown as more hospitals recommend their use in this region. The market share is expected to reach 28.3% in 2022.
With a growing demand for well-equipped facilities and advanced treatments in homes and hospitals, there is a growing demand for these beds in the market. The growing geriatric population and the presence of chronic diseases in these regions have contributed to the growth of the air fluidized therapy bed market in these regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
The Start-up Ecosystem: How Key Players Are Opening Frontiers for Future Growth?
Founded in 2020, Bistra Beds is a U.K based Internet-first brand that offers beds for home improvement. The product catalog includes divan beds, storage beds, upholstered beds, etc. It also includes a mattress, head bolder, divan base, etc.
Founded in 2018, Elicius is a technology solutions provider for hydrogen fuel cells. Offerings include tubular PEM fuel cell stack(energy storage fuel cell), rapid impedance spectroscopy(for battery management system), and others. Used in powering buildings, cars, trucks, portable electronic devices, and backup power systems.
Competitive Landscape: What are the Leading Players in the Air Fluidized Therapy Beds Market Up to?
In December 2021, Baxter acquired Hill-Rom for US$ 15 billion, making it the world's leading Medtech company. As a result, Baxter improved its technologies and supported patients in hospitals and at home more efficiently. Additionally, Baxter anticipates generating a high ROIC through this acquisition.
In April 2021, Axens Powering Integrated Solutions announced the sale and purchase agreement for the acquisition of Flowvision, an engineering company specializing in emission abatement systems for the reduction of nitrogen oxides in flue gas from the industry.
Key players
Hill-Rom,
Dolphin System
AURORA MFG,
American Medical Equipment
Blue Chip Medical
Akthel Healthcare BV
ArjoHuntleigh
Key Segments
By Indication:
Pressure Ulcers
Burns
Other Indications
By End User:
Hospitals
Ambulatory Surgical Centers
Other End Users
By Region:
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa
Frequently Asked Questions
The market has a 5.7% growth potential through 2033.
The global air fluidized therapy bed market size to reach US$ 1,135 million by 2033.
The global air fluidized therapy bed market advanced at a 4.1% HCAGR from 2018 to 2022.
The market is valued at US$ 653.5 million in 2023.
The estimated market share for the North American region is 35%.
From 2023 to 2033, the market share is anticipated to surpass 28.3%.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
5.3.1. Pressure Ulcers
5.3.2. Burns
5.3.3. Other Indications
5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Other End Users
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Indication
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Indication
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Indication
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Indication
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Indication
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Indication
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Indication
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Indication
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Indication
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Indication
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Indication
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Indication
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Indication
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Indication
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Indication
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Indication
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Indication
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Indication
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Indication
15.5.2.2. By End User
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Indication
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Indication
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Indication
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Indication
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Indication
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Indication
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Indication
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Indication
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Indication
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Indication
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Indication
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Indication
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Indication
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Indication
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Indication
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Indication
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Indication
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Indication
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Indication
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Hill-Rom,
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Dolphin System
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. AURORA MFG,
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. American Medical Equipment
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Blue Chip Medical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Akthel Healthcare BV
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. ArjoHuntleigh
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Envella
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Kinetic Concepts
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Denghuang Medical
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Redactron International BV
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Shandong Hesheng Medical Equipment Co., Ltd.
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Volume (Units) Forecast by Region, 2018 to 2033
Table 3: Global Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 4: Global Volume (Units) Forecast by Indication, 2018 to 2033
Table 5: Global Value (US$ Million) Forecast by End User, 2018 to 2033
Table 6: Global Volume (Units) Forecast by End User, 2018 to 2033
Table 7: North America Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: North America Volume (Units) Forecast by Country, 2018 to 2033
Table 9: North America Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 10: North America Volume (Units) Forecast by Indication, 2018 to 2033
Table 11: North America Value (US$ Million) Forecast by End User, 2018 to 2033
Table 12: North America Volume (Units) Forecast by End User, 2018 to 2033
Table 13: Latin America Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Latin America Volume (Units) Forecast by Country, 2018 to 2033
Table 15: Latin America Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 16: Latin America Volume (Units) Forecast by Indication, 2018 to 2033
Table 17: Latin America Value (US$ Million) Forecast by End User, 2018 to 2033
Table 18: Latin America Volume (Units) Forecast by End User, 2018 to 2033
Table 19: Western Europe Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: Western Europe Volume (Units) Forecast by Country, 2018 to 2033
Table 21: Western Europe Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 22: Western Europe Volume (Units) Forecast by Indication, 2018 to 2033
Table 23: Western Europe Value (US$ Million) Forecast by End User, 2018 to 2033
Table 24: Western Europe Volume (Units) Forecast by End User, 2018 to 2033
Table 25: Eastern Europe Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: Eastern Europe Volume (Units) Forecast by Country, 2018 to 2033
Table 27: Eastern Europe Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 28: Eastern Europe Volume (Units) Forecast by Indication, 2018 to 2033
Table 29: Eastern Europe Value (US$ Million) Forecast by End User, 2018 to 2033
Table 30: Eastern Europe Volume (Units) Forecast by End User, 2018 to 2033
Table 31: South Asia and Pacific Value (US$ Million) Forecast by Country, 2018 to 2033
Table 32: South Asia and Pacific Volume (Units) Forecast by Country, 2018 to 2033
Table 33: South Asia and Pacific Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 34: South Asia and Pacific Volume (Units) Forecast by Indication, 2018 to 2033
Table 35: South Asia and Pacific Value (US$ Million) Forecast by End User, 2018 to 2033
Table 36: South Asia and Pacific Volume (Units) Forecast by End User, 2018 to 2033
Table 37: East Asia Value (US$ Million) Forecast by Country, 2018 to 2033
Table 38: East Asia Volume (Units) Forecast by Country, 2018 to 2033
Table 39: East Asia Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 40: East Asia Volume (Units) Forecast by Indication, 2018 to 2033
Table 41: East Asia Value (US$ Million) Forecast by End User, 2018 to 2033
Table 42: East Asia Volume (Units) Forecast by End User, 2018 to 2033
Table 43: Middle East and Africa Value (US$ Million) Forecast by Country, 2018 to 2033
Table 44: Middle East and Africa Volume (Units) Forecast by Country, 2018 to 2033
Table 45: Middle East and Africa Value (US$ Million) Forecast by Indication, 2018 to 2033
Table 46: Middle East and Africa Volume (Units) Forecast by Indication, 2018 to 2033
Table 47: Middle East and Africa Value (US$ Million) Forecast by End User, 2018 to 2033
Table 48: Middle East and Africa Volume (Units) Forecast by End User, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Value (US$ Million) by Indication, 2023 to 2033
Figure 2: Global Value (US$ Million) by End User, 2023 to 2033
Figure 3: Global Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Volume (Units) Analysis by Region, 2018 to 2033
Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 9: Global Volume (Units) Analysis by Indication, 2018 to 2033
Figure 10: Global Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 11: Global Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 12: Global Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 13: Global Volume (Units) Analysis by End User, 2018 to 2033
Figure 14: Global Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 15: Global Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 16: Global Attractiveness by Indication, 2023 to 2033
Figure 17: Global Attractiveness by End User, 2023 to 2033
Figure 18: Global Attractiveness by Region, 2023 to 2033
Figure 19: North America Value (US$ Million) by Indication, 2023 to 2033
Figure 20: North America Value (US$ Million) by End User, 2023 to 2033
Figure 21: North America Value (US$ Million) by Country, 2023 to 2033
Figure 22: North America Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 23: North America Volume (Units) Analysis by Country, 2018 to 2033
Figure 24: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 25: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 26: North America Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 27: North America Volume (Units) Analysis by Indication, 2018 to 2033
Figure 28: North America Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 29: North America Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 30: North America Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 31: North America Volume (Units) Analysis by End User, 2018 to 2033
Figure 32: North America Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 33: North America Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 34: North America Attractiveness by Indication, 2023 to 2033
Figure 35: North America Attractiveness by End User, 2023 to 2033
Figure 36: North America Attractiveness by Country, 2023 to 2033
Figure 37: Latin America Value (US$ Million) by Indication, 2023 to 2033
Figure 38: Latin America Value (US$ Million) by End User, 2023 to 2033
Figure 39: Latin America Value (US$ Million) by Country, 2023 to 2033
Figure 40: Latin America Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 41: Latin America Volume (Units) Analysis by Country, 2018 to 2033
Figure 42: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 43: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 44: Latin America Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 45: Latin America Volume (Units) Analysis by Indication, 2018 to 2033
Figure 46: Latin America Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 47: Latin America Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 48: Latin America Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 49: Latin America Volume (Units) Analysis by End User, 2018 to 2033
Figure 50: Latin America Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 51: Latin America Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 52: Latin America Attractiveness by Indication, 2023 to 2033
Figure 53: Latin America Attractiveness by End User, 2023 to 2033
Figure 54: Latin America Attractiveness by Country, 2023 to 2033
Figure 55: Western Europe Value (US$ Million) by Indication, 2023 to 2033
Figure 56: Western Europe Value (US$ Million) by End User, 2023 to 2033
Figure 57: Western Europe Value (US$ Million) by Country, 2023 to 2033
Figure 58: Western Europe Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 59: Western Europe Volume (Units) Analysis by Country, 2018 to 2033
Figure 60: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 61: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 62: Western Europe Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 63: Western Europe Volume (Units) Analysis by Indication, 2018 to 2033
Figure 64: Western Europe Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 65: Western Europe Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 66: Western Europe Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 67: Western Europe Volume (Units) Analysis by End User, 2018 to 2033
Figure 68: Western Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 69: Western Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 70: Western Europe Attractiveness by Indication, 2023 to 2033
Figure 71: Western Europe Attractiveness by End User, 2023 to 2033
Figure 72: Western Europe Attractiveness by Country, 2023 to 2033
Figure 73: Eastern Europe Value (US$ Million) by Indication, 2023 to 2033
Figure 74: Eastern Europe Value (US$ Million) by End User, 2023 to 2033
Figure 75: Eastern Europe Value (US$ Million) by Country, 2023 to 2033
Figure 76: Eastern Europe Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 77: Eastern Europe Volume (Units) Analysis by Country, 2018 to 2033
Figure 78: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 79: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 80: Eastern Europe Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 81: Eastern Europe Volume (Units) Analysis by Indication, 2018 to 2033
Figure 82: Eastern Europe Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 83: Eastern Europe Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 84: Eastern Europe Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 85: Eastern Europe Volume (Units) Analysis by End User, 2018 to 2033
Figure 86: Eastern Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 87: Eastern Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 88: Eastern Europe Attractiveness by Indication, 2023 to 2033
Figure 89: Eastern Europe Attractiveness by End User, 2023 to 2033
Figure 90: Eastern Europe Attractiveness by Country, 2023 to 2033
Figure 91: South Asia and Pacific Value (US$ Million) by Indication, 2023 to 2033
Figure 92: South Asia and Pacific Value (US$ Million) by End User, 2023 to 2033
Figure 93: South Asia and Pacific Value (US$ Million) by Country, 2023 to 2033
Figure 94: South Asia and Pacific Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: South Asia and Pacific Volume (Units) Analysis by Country, 2018 to 2033
Figure 96: South Asia and Pacific Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 97: South Asia and Pacific Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 98: South Asia and Pacific Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 99: South Asia and Pacific Volume (Units) Analysis by Indication, 2018 to 2033
Figure 100: South Asia and Pacific Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 101: South Asia and Pacific Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 102: South Asia and Pacific Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 103: South Asia and Pacific Volume (Units) Analysis by End User, 2018 to 2033
Figure 104: South Asia and Pacific Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 105: South Asia and Pacific Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 106: South Asia and Pacific Attractiveness by Indication, 2023 to 2033
Figure 107: South Asia and Pacific Attractiveness by End User, 2023 to 2033
Figure 108: South Asia and Pacific Attractiveness by Country, 2023 to 2033
Figure 109: East Asia Value (US$ Million) by Indication, 2023 to 2033
Figure 110: East Asia Value (US$ Million) by End User, 2023 to 2033
Figure 111: East Asia Value (US$ Million) by Country, 2023 to 2033
Figure 112: East Asia Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 113: East Asia Volume (Units) Analysis by Country, 2018 to 2033
Figure 114: East Asia Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 115: East Asia Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 116: East Asia Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 117: East Asia Volume (Units) Analysis by Indication, 2018 to 2033
Figure 118: East Asia Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 119: East Asia Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 120: East Asia Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 121: East Asia Volume (Units) Analysis by End User, 2018 to 2033
Figure 122: East Asia Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 123: East Asia Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 124: East Asia Attractiveness by Indication, 2023 to 2033
Figure 125: East Asia Attractiveness by End User, 2023 to 2033
Figure 126: East Asia Attractiveness by Country, 2023 to 2033
Figure 127: Middle East and Africa Value (US$ Million) by Indication, 2023 to 2033
Figure 128: Middle East and Africa Value (US$ Million) by End User, 2023 to 2033
Figure 129: Middle East and Africa Value (US$ Million) by Country, 2023 to 2033
Figure 130: Middle East and Africa Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 131: Middle East and Africa Volume (Units) Analysis by Country, 2018 to 2033
Figure 132: Middle East and Africa Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: Middle East and Africa Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: Middle East and Africa Value (US$ Million) Analysis by Indication, 2018 to 2033
Figure 135: Middle East and Africa Volume (Units) Analysis by Indication, 2018 to 2033
Figure 136: Middle East and Africa Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 137: Middle East and Africa Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 138: Middle East and Africa Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 139: Middle East and Africa Volume (Units) Analysis by End User, 2018 to 2033
Figure 140: Middle East and Africa Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 141: Middle East and Africa Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 142: Middle East and Africa Attractiveness by Indication, 2023 to 2033
Figure 143: Middle East and Africa Attractiveness by End User, 2023 to 2033
Figure 144: Middle East and Africa Attractiveness by Country, 2023 to 2033
